REPORTED PARTICIPANT
ABU DHABI INVESTMENT AUTHORITY - WAY
ABU DHABI INVESTMENT AUTHORITY - WAY: 6 reported NSE/BSE deal sides from 2022-12-22 to 2026-06-17.
Recent disclosures
| Date | Company | Participant | Side | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-06-17NSE · Block | CORONA Remedies Limited | ABU DHABI INVESTMENT AUTHORITY - WAY | Buy | 39,130 | ₹1730.00 | ₹6.77 Cr |
| 2024-06-27NSE · Bulk | CSB Bank Limited | ABU DHABI INVESTMENT AUTHORITY - WAY | Buy | 1,015,000 | ₹352.75 | ₹35.80 Cr |
| 2024-06-27NSE · Block | CSB Bank Limited | ABU DHABI INVESTMENT AUTHORITY - WAY | Buy | 1,015,000 | ₹352.75 | ₹35.80 Cr |
| 2024-05-17NSE · Block | PB Fintech Limited | ABU DHABI INVESTMENT AUTHORITY - WAY | Buy | 154,000 | ₹1325.15 | ₹20.41 Cr |
| 2024-02-27BSE · Bulk | CMS Info Systems Limited | ABU DHABI INVESTMENT AUTHORITY - WAY | Buy | 846,560 | ₹370.05 | ₹31.33 Cr |
| 2022-12-22NSE · Block | Ajanta Pharma Ltd | ABU DHABI INVESTMENT AUTHORITY - WAY | Buy | 173,683 | ₹1160.10 | ₹20.15 Cr |